These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6191822)

  • 1. Antithrombotic treatment.
    Buckler P; Douglas AS
    Br Med J (Clin Res Ed); 1983 Jul; 287(6386):196-8. PubMed ID: 6191822
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
    McNicol GP
    Lancet; 1980 Oct; 2(8197):736-8. PubMed ID: 6106840
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet inhibition in the management of thrombosis.
    Didisheim P; Kazmier FJ; Fuster V
    Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
    Castaldi PA
    Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
    Hirsh J
    Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention of myocardial infarction--the present state of the ART.
    Mitchell JR
    Br Med J; 1980 May; 280(6223):1128-30. PubMed ID: 7000236
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleeding associated with antithrombotic therapy.
    Kelton JG; Hirsh J
    Semin Hematol; 1980 Oct; 17(4):259-91. PubMed ID: 6160618
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic drugs: part II.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(2):132-57. PubMed ID: 786606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1977 Oct; 121(44):1748-54. PubMed ID: 335258
    [No Abstract]   [Full Text] [Related]  

  • 10. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of thrombotic diseases.
    Douglas AS
    Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
    Loo J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):172-94. PubMed ID: 50982
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet therapy and cerebrovascular diseases.
    Meloche JP
    Adv Otorhinolaryngol; 1982; 28():100-3. PubMed ID: 7051785
    [No Abstract]   [Full Text] [Related]  

  • 14. Using antithrombotic therapy in ischemic cerebrovascular disease.
    Gotshall RA; Harker LA
    Geriatrics; 1977 Nov; 32(11):101-4. PubMed ID: 924145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 16. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 17. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
    Shalaev SV
    Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with antiplatelet drugs. Current status of knowledge].
    Dettori AG; Pini M; Quintavalla R
    Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Benefits and dangers of preventive thinking in medicine--prevention of thromboembolism].
    Bolte HD
    Internist (Berl); 1981 Feb; 22(2):72-8. PubMed ID: 6163745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.